T2 high asthma is characterized by reduced lung function, poor asthma control, increased IgE levels, increased responsiveness to ICS treatment and persistent eosinophilic inflammation mediated by cytokines such as IL-4, IL-5 and IL-13. This evidence concerns the gene IGHE and asthma.